Author:
Lin Nancy U.,Sarantopoulos Stefanie,Stone James R.,Galinsky Ilene,Stone Richard M.,Deangelo Daniel J.,Soiffer Robert J.
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Reference12 articles.
1. Cohen MH, Williams G, Johnson JR, et al. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia. Clin Cancer Res.2002;8: 935-942.
2. Hoelzer D, Gokbuget N, Ottman OG. Targeted therapies in the treatment of Philadelphia chromosome–positive acute lymphoblastic leukemia. Semin Hematol.2002;39(suppl 3): 32-37.
3. Dager R, Cohen M, Williams G, et al. Approval summary: imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res.2002;8: 3034-3038.
4. Silver RT. Imatinib mesylate (Gleevec™) reduces phlebotomy requirements in polycythemia vera. Leukemia. 2003;17: 1186-1187.
5. O'Brien SG, Guilhot F, Larson R, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med.2003;348: 994-1004.
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献